Crawford Lake Capital Management, LLC Global Blood Therapeutics, Inc. Transaction History

Crawford Lake Capital Management, LLC

2 transactions

Quarter	Operation	Price Per share	shares change	shares Held	SEC Form
Q1 2020 May 15, 2020	SELL	$41.72 - $87.2 $2.35 Million - $4.9 Million	-56,210 Closed	0 $0
Q4 2019 Feb 14, 2020	BUY	$45.7 - $81.86 $2.57 Million - $4.6 Million	56,210 New	56,210 $4.47 Million

288K

Ticker GBT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 67,476,200
Market Cap $4.62B
Description
Global Blood Therapeutics, Inc., a biopharmaceutical company, engages in the discovery, development, and delivery of treatments for underserved patient communities with sickle cell disease (SCD). The company offers Oxbryta tablets, an oral, once-daily therapy for SCD. It also evaluates the safety and pharmacokinetics of single and multiple doses...

Get notified when there are updates to the investment portfolio of Crawford Lake Capital Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Crawford Lake Capital Management, LLC with notifications on news.